Massive Bio | 43,981 followers on LinkedIn. An AI-driven platform connecting cancer patients to bio-pharmaceutical clinical trials. | Massive Bio is a health-tech company transforming how cancer patients access clinical trials. Operating in 17 countries across North America, Europe, and LATAM, we use proprietary AI technology to match patients to the most appropriate clinical trials—regardless of location, income, or cancer type. We partner with pharmaceutical companies, CROs, and healthcare institutions to accelerate oncology trial enrollment, reduce dropout rates, and deliver real-world evidence